NOS2 knockdown by RNA interference strategy or by specific inhibitors, negatively affects the proliferation and invasiveness of glioblastoma cells [28, 29] and was able to reduce the progression of subcutaneous and intracranial human glioma xenografts in mice [25]. The gene discussed is NOS2; the disease is central nervous system cancer.